The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline’s former blockbuster diabetes drug Avandia.
Read more
FDA reviewing heart risks of Glaxo diabetes pill Avandia
Posted in Drugs
-
-
Recent Posts
-
-